# Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

> **NCT00256295** · PHASE2 · TERMINATED · sponsor: **Sai-Hong Ignatius Ou** · enrollment: 8 (actual)

## Conditions studied

- Cancer of the Head and Neck

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT00256295
- **Lead sponsor:** Sai-Hong Ignatius Ou
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** 2008-02
- **Final completion:** 2011-10
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2017-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256295, "Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00256295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*